The current valuation score of Exelixis Inc is 7.88, ranking 191 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is 17.72, which is 377.08% below the recent high of 84.56 and 20.24% above the recent low of 14.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.